ArticleBioengineered2024
Statement of Retraction: Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.